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Blood typing is the most important test for both transfusion recipients and blood donors. In this
paper, a low cost disposable blood typing integrated microfluidic biochip has been designed,
fabricated and characterized. In the biochip, flow splitting microchannels, chaotic micromixers,
reaction microchambers and detection microfilters are fully integrated. The loaded sample blood
can be divided by 2 or 4 equal volumes through the flow splitting microchannel so that one can
perform 2 or 4 blood agglutination tests in parallel. For the purpose of obtaining efficient reaction
of agglutinogens on red blood cells (RBCs) and agglutinins in serum, we incorporated a serpentine
laminating micromixer into the biochip, which combines two chaotic mixing mechanisms of
splitting/recombination and chaotic advection. Relatively large area reaction microchambers were
also introduced for the sake of keeping the mixture of the sample blood and serum during the
reaction time before filtering. The gradually decreasing multi-step detection microfilters were
designed in order to effectively filter the reacted agglutinated RBCs, which show the
corresponding blood group. To achieve the cost-effectiveness of the microfluidic biochip for
disposability, the biochip was realized by the microinjection moulding of COC (cyclic olefin
copolymer) and thermal bonding of two injection moulded COC substrates in mass production
with a total fabrication time of less than 20 min. Mould inserts of the biochip for the
microinjection moulding were fabricated by SU-8 photolithography and the subsequent nickel
electroplating process. Human blood groups of A, B and AB have been successfully determined
with the naked eye, with 3 ml of the whole sample bloods, by means of the fabricated biochip
within 3 min.
Introduction
Blood typing is the most important test performed for blood
donors and recipients whenever transfusion is required. The
critical importance of blood typing, especially for ABO blood
group, stems from the fact that the all agglutinins of the ABO
system fix complement and they could even cause intravascular
hemolysis of incompatible red cells. Therefore, a mistyping of
the ABO blood group of recipients or donors brings about
an undesirable tragic result. The blood group is generally
determined by observing agglutination results of the red blood
cells (RBCs) reacting with the corresponding blood serum.
The agglutination of RBCs shows the presence of antigens
(agglutinogens) on the RBCs corresponding to antibodies
(agglutinins) in the serum. The determination of the ABO
blood group is possible by two different typing procedures: red
cell typing (also called forward grouping) and serum typing
(reverse grouping). The purpose of performing both cell and
serum typing is to confirm the agglutination results of each
other. From these typing procedures, one of the blood groups
of A, B, AB and O can be accurately assigned to the test blood
sample because red cells agglutinate each other when they react
with the corresponding blood grouping serum, Anti-A or
Anti-B, as mentioned above. Blood typing sera, Anti-A,
Anti-B and Anti-AB, are obtained from the sera of blood
group B persons, A persons and O persons, respectively. It
should be mentioned that Anti-AB is not a simple mixture of
Anti-A and Anti-B but a particular serum of blood group O
persons, which can be applied to determining weak antigens of
red cells, in particular weak-A antigens (e.g., A2, A3, Aint, etc).
1
It should also be noted that there are subgroups of A and B,
which are grouped as weak-A and weak-B (e.g., B3, Bint, etc.),
respectively. Since they result in weak agglutination in red cell
typing, the test blood sample could be even mistyped as group
O. As mentioned above, the mismatched transfusion brings
about intravascular hemolysis of the patient. To prevent this
mistyping from happening, special attention is required for
doing red cell typing.
Among many blood typing methods, a plate method,1,2 a gel
card method3,4 and an automated blood bank test system5,6
have been regarded as the most representative blood typing
methods. The plate method is relatively simple but tedious due
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to its whole manual process. Furthermore, it may result in
undesirable mistyping of blood group of a sample blood due to
poor reliability and user performance. The gel card method is
regarded as a semi-automatic and relatively accurate test
method. However, the test kit is expensive and it requires a
practised hand and extra equipment, such as a centrifuge. The
blood bank system offers fully automated blood typing of
numerous bloods. This system, however, is very expensive and
huge so that only major medical centers or blood banks can
maintain it. Recently, Lee et al.7 presented a miniaturized
blood typing system fabricated by the micro-stereolithography
technology, which assembled flow splitting channels, chaotic
micromixers8 and reaction chambers. They used 20 ml of a
sample blood per test line to determine the blood group and
showed that an efficient micromixer should be required to get
reliable agglutination reaction in microchannels. However,
their system has the limitations of disposability and portability
due to the high fabrication cost and requirement of extra
detection equipment to observe agglutinated red cells in the
reaction chambers.7
Therefore, the previous blood typing methods including the
plate, gel card, automated system and miniaturized system
explained above have a limitation for emergency blood typing
due to the requirement of extra-large scale equipment and
much testing time for blood sedimentation. In other words,
they are not suitable for point-of-care monitoring and treat-
ment, especially for the emergency case. Furthermore, the
previous methods generally require a blood volume of more
than 20 ml.5 If the repeated collection of blood from patients
is required, withdrawing blood becomes a critical problem,
in particular for infants though the test blood volume is
relatively small.
In this regard, we propose a low cost, lab-on-a-chip for
blood typing, integrated microfluidic biochip of compact size,
which requires a very small sample blood volume of the order
of 1 ml. In the following sections we introduce the design and
operation process of the microfluidic biochip and components
integrated in the biochip: flow splitting microchannels, chaotic
micromixers,9 reaction microchambers and detection micro-
filters. As the cost-effective mass fabrication method of the
biochip, a microinjection moulding process with electroplated
nickel mould inserts and a subsequent thermal bonding
process are applied. Then, we present successful blood typing
results of blood groups of A, B and AB by means of the
fabricated biochip.
Theories and design of biochip
Determination of ABO blood group
The ABO blood group can be determined by reacting sample
RBCs with the corresponding blood grouping serum, e.g.,
Anti-A and Anti-B. For instance, RBCs of blood group A are
agglutinated by Anti-A. Table 1 lists the determination method
of ABO blood group.
In general, both red cell typing and serum typing are carried
out for the accurate determination of blood group in order to
compare the agglutination results of the other test. Red cell
typing could have seven test channels, which contain
sample RBCs with standard Anti-A, Anti-B, Anti-AB,
Anti-A1, Anti-H, Anti-D and negative control, to determine
blood groups of A, B, AB, O, Rh (D) and also weak-A.
Anti-A1 and Anti-H are used for determining weak blood sub-
groups and negative control is required to check the self-
agglutination of the sample blood. For serum typing, three
test channels, which contain sample serum with standard red
cell-A, cell-B and cell-O, could be applied to confirm the test
result of the red cell typing.
Overall design and operation process of biochip
Fig. 1 shows a schematic diagram of one blood typing unit in
a microfluidic biochip designed in this study. It might be
mentioned that one biochip, in this study, was designed to
have two blood typing units and each blood typing unit has
four test lines. The designed blood typing microfluidic biochip
fully integrates flow splitting microchannels, chaotic micro-
mixers, reaction microchambers and detection microfilters, as
indicated in Fig. 1. The present biochip is composed of two
substrate layers to increase the storage volume capacity of the
reaction chamber and to consider the design of a serpentine
laminating micromixer (SLM)9 as a chaotic micromixer. The
thickness of all the microfluidic channels in each substrate is
designed to be 60 mm.
A blood typing process by means of the biochip in this study
runs as follows. The constant volume (about 1–1.5 ml per test
line) of a sample blood (RBCs) and the standard sera are
loaded into the corresponding inlets, as indicated in Fig. 1(a)
(process step (i) in Fig. 1(b)). The loaded sample blood and
standard sera are injected into the biochip through the flow
splitting microchannels via a syringe pump, for example. In
this case, the stream of the sample blood splits into and is
guided to 2 or 4 separate microchannels (process step (ii)).
Both the divided blood stream and the corresponding serum
stream are introduced into each connected chaotic micromixer,
SLM, to be efficiently mixed with each other in order to induce
the effective agglutination of RBCs with the corresponding
antibodies (process step (iii)). The mixtures of blood and serum
streams are then led to each reaction microchamber. The
reaction microchamber keeps the mixture during the appro-
priate reaction time about 1–3 min for agglutination of RBCs.
It should be mentioned that, in the present study, we stopped
the syringe pump at this process step to eliminate the driving
pressure applied to the biochip, thereby keeping the mixtures
inside the reaction microchambers during the reaction time
(process step (iv)). The reacted (or non-reacted) mixture of
blood RBCs and serum passes through each detection
microfilter and finally flows out from each outlet (process
Table 1 Determination of ABO blood group from reaction results
Reaction result of sample red blood cells with—
ABO blood
group typingAnti-Aa Anti-B
(2) (2) O
(+) (2) A
(2) (+) B
(+) (+) AB
a (+) and (2) mean the existence and absence of agglutinated red
blood cells (filtered cells in this case, which will be explained later),
respectively.
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steps (v) and (vi)). The large size reacted agglutinated cells are
effectively filtered inside each detection microfilter, whereas
non-reacted RBCs easily pass the detection microfilters.
Therefore, one can observe the agglutination results by the
naked eye without any extra large-scale equipment such
as a microscope, and thus one can easily determine the blood
group of the test blood sample by means of the biochip alone.
Flow splitting microchannel
In the present biochip, the loaded sample blood is divided into
2 or 4 equal volumes through the flow splitting microchannels,
as explained in Fig. 1. The 4 divided streams of the sample
blood and sera injected are finally guided to the front of the
subsequent micromixers by means of the flow splitting
microchannels. The width of the main channel was designed
to be 500 mm in this study, and thereby all of the micro-
channels have the same width and thickness.
It might be noted that one can perform 2 or 4 blood
agglutination tests in parallel with the present design. For the
case of 2 blood agglutination tests (e.g., with Anti-A and
Anti-B, that is a simple ABO blood typing), one can utilize two
of four test lines in the one blood typing unit in Fig. 1 by
opening two inlets of sera and the corresponding two outlets
(of course, also opening blood inlet). For the 4 blood
agglutination tests (e.g., with Anti-A, Anti-B, Anti-D and
Anti-A1), all the four test lines are utilized by opening all inlets
and outlets. Finally, it might be mentioned that when there
exists any need to design multiple flow splitting microchannels
having odd splitting channels or different splitting volumes,
one can utilize the microchannel design equations suggested in
ref. 10 to achieve that.
Fig. 1 Schematic diagram of one blood typing unit of a microfluidic biochip in which flow splitting microchannels, chaotic micromixers, reaction
microchambers and detection microfilters are fully integrated. The reaction microchamber can store about 3 ml of a mixture of blood and serum.
The agglutinated red blood cells formed by antigen–antibody reaction between red blood cells and test serum can be effectively observed by the
efficient detection microfilters (insets are enlarged views of the microfilter): (a) top view; and (b) three-dimensional view.
796 | Lab Chip, 2006, 6, 794–802 This journal is  The Royal Society of Chemistry 2006
Pu
bl
ish
ed
 o
n 
04
 A
pr
il 
20
06
. D
ow
nl
oa
de
d 
on
 2
8/
04
/2
01
5 
05
:4
8:
31
. 
View Article Online
Serpentine laminating micromixer
As was mentioned above, for accurate blood typing efficient
mixing of RBCs and serum is definitely desired.1,7 Because of
the low Reynolds number (Re) of the microchannel flow in the
biochip, however, it is impossible to expect turbulent mixing of
two fluid flows. In this regard, we have newly developed an
efficient chaotic micromixer having a simple geometry, named
serpentine laminating micromixer (SLM), as indicated in
Fig. 1,9 to effectively incorporate into the present disposable
microfluidic biochip. The SLM combines two general
chaotic mixing mechanisms of splitting/recombination
and chaotic advection, thereby resulting in the higher level of
chaotic mixing in the microchannel. In the present SLM, eight
‘‘F’’-shaped mixing units are successively arranged in two
layers. The main channel width of the F-shaped mixing unit is
250 mm.
The SLM has a great advantage of mass producible simple
geometry while maintaining the higher level of chaotic mixing
over the wide range of Re. Furthermore, with the SLM, one
could effectively reduce the chances of non-specific adsorption
of proteins (antibodies in this study) to the channel surface by
decreasing contact area between the surface of the micro-
channel and stream.
Two sample RBCs and standard serum streams injected
from the connected flow splitting microchannels are efficiently
mixed up through the SLM. Each mixture of RBCs and serum
is then led to the subsequent reaction microchamber. For the
detailed mixing mechanism and characterization of the SLM,
one may refer to ref. 9.
Reaction microchamber
In the present blood typing method with the microfluidic
biochip, the blood group of the sample blood is determined by
observing the agglutination of RBCs by antibodies in serum.
In this regard, the observation of agglutination (in this case,
filtering) should be carried out after the proper reaction time
of agglutination of RBCs. Therefore, the mixture of RBCs
and serum should be kept during the reaction time of about
1–3 min before filtering for detection.
Fig. 1 schematically shows the reaction microchamber
between the SLM and the detection microfilter. The width
and total thickness of the reaction chamber was designed to
become 2500 mm and 120 mm (two layers), respectively. As was
mentioned before, the reaction microchamber is patterned
both top and bottom substrates for the purpose of increasing
the storage volume capacity of the chamber, so that the
reaction microchamber can contain about 3.3 ml of mixture of
blood and serum.
After the prescribed reaction time, reacted (or non-reacted)
mixtures of blood and serum are injected into the connected
detection microfilters for observation of agglutination.
Detection microfilter
In the present study, we have designed a gradually decreasing
multi-step detection microfilter to observe agglutinated red
cells with the naked eye, without large optical detection
systems, for the purpose of achieving the portability as well as
the disposability of the biochip. The typical size of a red
blood cell is 7.6 mm in diameter and 2.3 mm in thickness.
Interestingly, the antigen–antibody reaction between RBCs
and the corresponding serum could form large size aggluti-
nated RBCs even greater than 100 mm. One could determine
the size of the filter gap by considering the usual size of
agglutinated red cells.
Insets of Fig. 1 schematically show the detection microfilters
designed in this study. Various trapezoidal planar shaped
micropillars that make the filters are periodically arranged at
the regular interval of 500 mm in the downchannel direction.
The trapezoidal shape of the micropillars makes a wide inlet
and a narrow outlet of the filter gaps. This wide inlet guides the
injected agglutinated or non-agglutinated RBCs to be easily
flowed into the narrow outlet so that it enhances the efficiency
of the microfilter. The detection microfilter was designed to
have five gradually decreasing outlet filter gaps, i.e., the
minimum distances between the adjacent micropillars in the
transverse direction, along the downstream direction: 200 mm
(2 columns), 150 mm (2 columns), 100 mm (6 columns), 80 mm
(10 columns) and 50 mm (10 columns) (see electronic
supplementary information (ESI) for detailed dimensions of
the microfilter{). It might be mentioned that we determined
the minimum size of the micropillar features and the filter gaps
as 50 mm, taking into account processing conditions of
photolithography and microinjection moulding processes,
which are the fabrication method of the present disposable
microfluidic biochip. With the present design of the micro-
filter, normal RBCs can easily pass the filter gaps without any
interference, whereas the large size agglutinated RBCs of
which the size is greater than 50 mm could not pass the filter
gaps and thereby are filtered during the flow through the
microfilter.
Fabrication
Fabrication of mould insert
To realize the integrated microfluidic biochip in mass
production is one of the principal objectives of this work.
The biochip was realized by means of a microinjection
moulding process, which is one of the most promising mass
production methods of polymer materials. In this regard, it is
first required to fabricate mould inserts for the replication of
the substrates of the biochip with the microinjection moulding.
Typical materials used in a micromachining process, such as
silicon, photoresists or polymeric materials, cannot be directly
used as a mould or a mould insert due to their weak strength
or thermal properties in the microinjection moulding process.
It is desirable to use metallic materials which have appropriate
mechanical and thermal properties to endure both a high
pressure and a large temperature variation during the
replication process. Therefore, a metallic mould insert is used
rather than the silicon wafer or polymer substrate itself
for mass production with such replication technologies.
Otherwise, special techniques should be adopted as a replica-
tion method, e.g., casting of PDMS [poly(dimethylsiloxane)]
elastomer.11 In this study, nickel mould inserts were fabricated
for the biochip by a nickel electroplating process with SU-8
photoresist patterns on nickel substrates.
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Fig. 2 illustrates the schematic diagram of the whole
fabrication process of the blood typing integrated microfluidic
biochip. The fabrication process of the mould inserts is as
follows (Fig. 2(a)–2(d)). First of all, two chrome photomasks
corresponding to the top and bottom layers of the biochip
were fabricated based on the design shown in Fig. 1. Two
nickel substrates, of which the diameter and thickness are
3 inch and 1.5 mm, respectively, were prepared as the mould
inserts for the microinjection moulding process. The nickel
disks were cleaned and then dried in a 120 uC oven for about
2 h before the spin coating process.
In order to improve the adhesion between the nickel surface
and the thick negative photoresist of SU-8, first an adhesion
promoter, OmniCoat2 (Microchem Corp., MA, USA), was
spin coated over the nickel substrates at a speed of 3000 rpm
for 30 s and baked on the hot plate at 200 uC for 1 min. The
SU-8 2075 (Microchem Corp., MA, USA) was spin coated on
the baked thin OmniCoat2 layer at a speed of 950 rpm for
45 s. After spin coating, a soft baking process was carefully
performed at 65 uC for 10 min and at 95 uC for 1 h and 45 min.
Then, UV light was exposed to the soft baked SU-8 and
OmniCoat2 layers on the nickel substrates with a total dose
of 250 mJ cm22, as schematically shown in Fig. 2(a). After the
UV exposure, a post exposure baking (PEB) process was
carried out at 65 uC for 10 min and at 95 uC for 10 min.
Then, both SU-8 and OmniCoat2 layers were developed by
immersing the nickel substrates into both a SU-8 developer
and an OmniCoat2 developer (Microposit MF 319) to obtain
masters for the electroplating process as depicted in Fig. 2(b).
As a final step of the mould insert fabrication, the
electroplating process was carried out in a nickel electroplating
bath with the prepared electroplating masters at a current
density of 10 mA cm22 for 6 h (Fig. 2(c)). Finally, two nickel
mould inserts, which contain 60 mm thick electroplated nickel
microstructures on the nickel substrates, of the microfluidic
biochip for the microinjection moulding were achieved after
stripping the residual SU-8 2075 and OmniCoat2 layers by
immersing them in a stripper (Remover PG), as schematically
shown in Fig. 2(d). It should be noted here that in order to
realize the precise alignment of two polymer layers of the
biochip during the bonding stage, the cavities of pairs of pins
and holes, the complementary self-alignment microstructures,
were patterned on two nickel mould inserts as indicated in
Fig. 2(d).12 One may refer to ref. 12 for the detailed process of
this self-assembly technique.
Figs. 3 and 4 show the photographs and representative
titled SEM (scanning electron microscope) pictures of the two
fabricated nickel mould inserts. It might be noted that one
can clearly observe the minimal surface roughness of the
Fig. 2 Fabrication process of the blood typing integrated micro-
fluidic biochip: (a) UV photolithography, (b) SU-8 and OmniCoat2
layers patterned on the nickel substrates as masters for electroplating,
(c) electroplated nickel in the masters, (d) nickel mould inserts after
removing SU-8 and OmniCoat2 layers, (e) injection moulding of
COC substrates and (f) final microfluidic biochip after thermal
bonding.
Fig. 3 Mould inserts of the blood typing integrated microfluidic
biochip for the microinjection moulding process, which contain 60 mm
thick electroplated nickel positive relief on the nickel substrate: (a) top
side; and (b) bottom side.
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electroplated nickel positive relief on the nickel substrate from
the SEM pictures of Fig. 4.
Fabrication of biochip
As was discussed above, we applied the microinjection
moulding process as a mass production method for making
the microfluidic biochip in order to achieve cost-effectiveness.
Two polymer substrates of the biochip were replicated by
means of a conventional injection moulding machine
(Allrounders 220 M, Arburg) with the fabricated mould base
and mould inserts as shown schematically in Fig. 2(e). In this
case, cyclic olefin copolymer (COC; Topas 5013S-04, Ticona)
was chosen as the substrate material of the biochip after
considering its great advantages over the other thermoplastic
polymers in terms of physical and chemical properties and
biocompatibility.13,14 Table 2 lists the detailed processing
conditions of the microinjection moulding process applied in
this study. It should be noted that the total cycle time of the
present microinjection moulding process was less than 1 min
to replicate the COC substrate. Fig. 5 shows representative
titled SEM pictures of the replicated microstructures in the
COC substrate.
The microfluidic biochip was finally made by thermal
bonding of the two injection moulded COC substrates by
means of a hot embossing machine after drilling holes (0.8 mm
diameter drill bit) for fluidic interconnection for inlets and
outlets on the top side COC substrate, as depicted in Fig. 2(f).
The thermal bonding process was carried out at a heating
temperature of 123 uC and an applied pressure of 1.94 MPa
for a duration time of 10 min. It should be noted here that
thermal bonding of the present reaction microchamber
requires special attention to prevent the collapse of the
microchamber due to its large area. We could successfully
form the reaction microchamber without the collapse via a
holed pressure equalizing plate (HPEP) which includes holes of
the same size and shape as the reaction microchambers.15 One
may refer to the detailed bonding technique including the
fabrication of the HPEP in ref. 15. During the bonding
process, two replicated COC substrates were precisely aligned
via the self-alignment microstructures, as indicated in Fig. 2(f).
The final size of the individual biochip is 56 6 44 6 3.8 mm3.
It should be noted that the total fabrication cycle time of each
biochip (from the microinjection moulding to the thermal
bonding) was just less than 20 min (1 min for the injection
moulding, 3 min for the post processing of mechanical cutting
and drilling of injection moulded COC substrates and 11 min
for the thermal bonding). Fig. 6 shows the finally fabricated
integrated microfluidic biochip with two blood typing units in
which flow splitting microchannels, SLM’s, reaction micro-
chambers and detection microfilters are fully assembled.
ABO blood typing
Experimental
In this study, the red cell blood typing for ABO blood groups
was performed by means of human whole bloods and the
standard sera, Anti-A and Anti-B, in order to check the
feasibility of the developed microfluidic biochip. In this regard,
we prepared the biochip for the 2 blood agglutination tests via
two test lines. It might be mentioned that the blood stream
requires 2 times higher input flow rate than the sera streams
Fig. 4 Tilted SEM pictures of the electroplated nickel positive relief
(cavities) in the fabricated mould inserts: (a) flow splitting micro-
channel; (b) F-shape mixing unit of the SLM; and (c) detection
microfilter of 80 mm gap.
Table 2 Processing condition of the microinjection moulding process
Processing condition Value
Injection melt temperature 290 uC
Mould temperature 110 uC
Injection pressure 300 bar
Injection filling time 0.25 s
Packing pressure 300 bar
Packing time 2 s
Cooling time 30 s
Fig. 5 Tilted SEM pictures of the injection moulded microstructures
in the COC substrates: (a) flow splitting microchannel; (b) F-shape
mixing unit of the SLM; and (c) detection microfilter with 80 mm gap.
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since the blood stream splits into 2 sub-streams by the flow
splitting microchannel. To flexibly handle two different flow
rates of the blood and sera streams, two syringe pumps
(kdScientific Inc., KDS200) were utilized. Fig. 7 shows the
blood typing experimental setup. The experimental procedure
of blood typing according to the operation process introduced
above is as follows.
(1) First, three types of sample human blood (blood groups
of A, B and AB) were withdrawn from three healthy young
donors. (It might be mentioned that about 1 ml of sample
blood was withdrawn from each donor by means of a
disposable syringe.) The sample whole bloods were mixed
with the heparin in a 6:1 volume ratio to prevent coagulation.
(2) The test volume of 3 ml of each whole blood was loaded
into the blood inlet reservoir of each microfluidic biochip and
also each 3 ml of Anti-A and Anti-B (Murine IgM monoclonal,
Serologicals Ltd.) was loaded into serum inlet reservoirs, as
indicated in Fig. 7.
(3) The loaded sample whole blood and the standard sera
were injected into the biochip by means of two syringe pumps
with the help of saline as a working fluid through the tubing
until the blood and sera flow into the reaction microchambers
through the flow splitting microchannels and SLMs.
(4) The mixture of the whole blood and sera was kept for
about 2 min as the reaction time of agglutination.
(5) The saline was then injected into the biochip only
through the blood inlet (i.e., using only one syringe pump for
blood injection) until the reacted or non-reacted mixtures of
blood and sera pass through the detection microfilters and
then flow out from the outlets.
(6) We observed the detection microfilters, whether agglu-
tinated RBCs were filtered or not, with the naked eye and then
we finally determined the blood group of the three sample
bloods based on the filtering results.
In this study, we have also carried out the plate-type blood
typing in order to confirm the blood typing results from the
biochip. In the plate-type blood typing, each 20 ml of the
sample whole blood (i.e., a total of 40 ml of the whole blood
used) was first loaded at two test wells. Each 20 ml of Anti-A
and Anti-B was then loaded at the two test wells and they
were manually mixed with the already loaded blood. After
3 min of agglutination time, we observed the agglutination
results.
Blood typing results
To determine the proper operating flow rate, we carried out
the blood typing experiments, changing the flow rate of
the saline from the syringe pumps. At the high flow rate (e.g.,
50 ml min21), it was found that the agglutinated RBCs were
mechanically broken up while passing the detection microfilter
due to the high shear stress induced by the flow. According to
the parametric study on the flow rate, the optimal flow rate
was found to be 30 ml min21 for the ABO blood typing in the
present study. For this condition, Re becomes 2.0, based on
the plasma specific gravity and viscosity of 1.03 and 1.2 cP,
respectively.16 The SLM requires about 6 mm of a charac-
teristic required length to mix the two fluid streams around Re
of 2.0 according to our previous result.9 The present design of
the SLM has 10 mm of total length and therefore, under this
condition, we could expect the efficient mixing of the blood
and serum by means of the present SLM.
Fig. 8 shows the successful blood typing results of the three
sample bloods. Insets in Fig. 8 show microscope views of the
successfully filtered agglutinated RBCs and air entrapments in
the detection microfilters (and the reaction microchambers)
Fig. 6 Blood typing microfluidic biochip in which flow splitting
microchannels, SLMs, reaction microchambers and detection micro-
filters are fully integrated. Red dyed water was injected into one blood
typing unit of the biochip to enhance the observation.
Fig. 7 Blood typing experimental setup with the developed micro-
fluidic biochip: (a) schematic diagram of the configuration; and (b)
microfluidic biochip installed in the blood typing experimental setup.
Human whole blood and standard sera (Anti-A and Anti-B) were
already loaded.
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after flushing out. It should be noted that one can easily
observe the filtered agglutinated RBCs in the detection
microfilters by the naked eye from the blood typing results
in Fig. 8. Therefore, one is able to simply and precisely
determine the blood group of the sample bloods with the
blood typing integrated microfluidic biochip developed in this
study. We have carried out more than three blood typing tests
per each blood sample and confirmed all the successful
identification of agglutination of blood samples. Also, we
have found that the blood typing results of the biochip were in
exact accordance with the results of the plate-type blood
typing method performed in this study (see electronic
supplementary information{ for blood typing results of the
plate-type method).
It may be mentioned that the size of the agglutinated red
cells of blood group A is generally so large that they could
not pass the relatively narrow microchannel in front of the
microfilter, thereby frequently remaining in the reaction
microchamber, as shown in Fig. 8 (a) and (c). This might be
explained by the high reaction activity of the agglutinogen of
blood group A with the corresponding agglutinin.
Conclusions
In this study, we have designed, fabricated and characterized
a low-cost, disposable, integrated microfluidic biochip for
blood typing in which flow splitting microchannels, serpentine
laminating chaotic micromixers, reaction microchambers
and detection microfilters are fully incorporated. By means
of the present flow splitting microchannels, it was possible
to carry out 2 or 4 blood agglutination tests in parallel.
For efficient mixing of red blood cells (RBCs) and serum,
the serpentine laminating micromixer was introduced into
the biochip. The fully mixed RBCs and serum were kept
in the large area reaction microchamber in the biochip.
The agglutinated RBCs were successfully filtered by the
gradually decreasing detection microfilter, designed in this
study, and thereby one can easily and precisely determine the
blood group of sample bloods by means of the developed
biochip.
To achieve cost effectiveness of the biochip, we have
manufactured it by the microinjection moulding of COC
(cyclic olefin copolymer) and thermal bonding of two injection
moulded COC substrates with a total fabrication time of less
than 20 min. The mould inserts for the microinjection
moulding process were fabricated by SU-8 photolithography
and subsequent nickel electroplating.
For the feasibility test of the developed biochip, we have
demonstrated successful ABO blood typing results with the
fabricated biochip. Three kinds of human blood groups, A, B
and AB, were successfully determined with 3 ml of the whole
blood within a test time of 3 min by means of the fabricated
biochip.
Based on the results of the present work, we want to simply
mention the advantages of the present biochip in terms of cost,
rapidity, easiness and reliability, although it might be too early
to discuss this last item. The present biochip can reduce the
reagent cost since the biochip requires a smaller test volume
(about 3 ml) than the previous methods (more than 20 ml). The
fabrication cost of the biochip may be also less than the gel
card, automated system and miniaturized system, since we
applied a mass fabrication method to the fabrication of the
biochip. The microfluidic channel of the biochip increases
surface to volume ratio so that it could enhance the reaction of
agglutinogens on RBCs and agglutinins in serum, thereby
resulting in the fast testing time. Because of the compact size of
the biochip, it is easy to handle. The multi-step microfilter of
the biochip increases chances to filter out agglutinated RBCs
and, therefore, it can increase the reliability of the biochip.
Also, one can preserve the blood typing test result performed
with the biochip.
This integrated microfluidic biochip developed in this study
may form the basis of development of microfluidic devices
for automated diagnosis, suitable for the level of hospitals in
function and capacity. In addition to that, the proposed
biochip could be applied to clinical examinations based on
agglutination reactions in antigen–antibody reactions, not to
mention the blood typing.
Fig. 8 ABO blood typing results of the three sample bloods by means
of the blood typing integrated microfluidic biochip developed in this
study: (a) blood group A; (b) blood group B; and (c) blood group AB.
Insets in the figures are enlarged microscope views of the filtered
agglutinated red cells.
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